Fleury, Isabelle, and Eva Laverdure. “Bispecific Antibodies and Chimeric Antigen Receptor (CAR) T-Cell Therapy for Indolent Lymphoma”. Canadian Hematology Today 2, no. 3 (November 6, 2023): 5–11. Accessed May 15, 2024. https://canadianhematologytoday.com/article/view/2-3-fleury_laverdure.